wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36214463-6D7994A4-F485-4A80-AED0-FD426A9353ED
Q36214463-6D7994A4-F485-4A80-AED0-FD426A9353ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36214463-6D7994A4-F485-4A80-AED0-FD426A9353ED
A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.
P2860
Q36214463-6D7994A4-F485-4A80-AED0-FD426A9353ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36214463-6D7994A4-F485-4A80-AED0-FD426A9353ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f739946c0b85f666892923d548e961ac34ea7125
P2860
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.